Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
2.360
+0.060 (2.61%)
At close: Jul 2, 2026, 4:00 PM EDT
2.300
-0.060 (-2.54%)
After-hours: Jul 2, 2026, 7:57 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $3.51 million as of July 2, 2026. Its market cap has decreased by -18.90% in one year.
Market Cap
3.51M
Enterprise Value
-10.00M
1-Year Change
-18.90%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.11M to $3.51M, a decrease of -86.57%. That is a compound annual growth rate of -33.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 3.51M | 29.15% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.16% |
| Dec 29, 2023 | 4.76M | -39.11% |
| Dec 30, 2022 | 7.81M | -59.09% |
| Dec 27, 2021 | 19.09M | -26.88% |
| Aug 16, 2021 | 26.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 4.26M |
| Revelation Biosciences | 4.06M |
| Decoy Therapeutics | 4.05M |
| Matinas BioPharma Holdings | 4.04M |
| Onconetix | 3.99M |
| Artelo Biosciences | 3.83M |
| Propanc Biopharma | 3.28M |
| GRI Bio | 3.15M |